Indinavir Sulfate and Procardia XL
Determining the interaction of Indinavir Sulfate and Procardia XL and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Indinavir may increase the blood levels and effects of NIFEdipine. You may be more likely to experience serious side effects such as irregular heart rhythm, fluid retention, swelling, heart failure, and excessively low blood pressure. You may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. You should seek medical attention if you develop dizziness or fainting; sudden, unexplained weight gain; swelling of the hands, ankles, or feet; chest pain; or difficulty breathing during treatment with these medications. Avoid driving or operating hazardous machinery until you know how the medications affect you, and use caution when getting up from a sitting or lying position. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Coadministration with indinavir may increase the plasma concentrations and pharmacologic effects of calcium channel blockers, especially the dihydropyridines (e.g., amlodipine, felodipine, nicardipine, nifedipine, nisoldipine). The mechanism involves indinavir inhibition of intestinal and hepatic CYP450 3A4, the isoenzyme primarily responsible for the metabolic clearance of most calcium channel blockers.
MANAGEMENT: Close monitoring of clinical response and tolerance is recommended if calcium channel blockers are used in combination with indinavir. Dosage reduction may be required for the calcium channel blocker, particularly if it is a dihydropyridine. Patients should be advised to seek medical attention if they experience edema or swelling of the lower extremities; sudden, unexplained weight gain; difficulty breathing; chest pain or tightness; or hypotension as indicated by dizziness, fainting, or orthostasis.
- "Product Information. Crixivan (indinavir)." Merck & Co, Inc, West Point, PA.
Generic Name: indinavir
Brand name: Crixivan
Synonyms: Indinavir
Generic Name: nifedipine
Brand name: Adalat CC, Procardia, Procardia XL, Afeditab CR, Nifediac CC, Nifedical XL, Adalat
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Indinavir Sulfate-ProCentra
- Indinavir Sulfate-Prochieve
- Indinavir Sulfate-Prochieve (Progesterone Vaginal 4% Gel)
- Indinavir Sulfate-Prochieve (Progesterone Vaginal 8% Gel)
- Indinavir Sulfate-Prochlorperazine
- Indinavir Sulfate-Prochlorperazine Edisylate
- Procardia XL-Indiomin MB
- Procardia XL-Indium 111 Oxyquinoline
- Procardia XL-Indium DTPA
- Procardia XL-Indium In-111 Pentetreotide
- Procardia XL-Indium Oxyquinoline
- Procardia XL-Indocid